PennyStocksUpdate.biz is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
New York, NY -- (SBWIRE) -- 01/17/2013 -- Telik, Inc. (NASDAQ:TELK) shares dropped 12.06% and closed at $1.75. The company, on Jan. 11, said that it was notified that its product candidate, ezatiostat HCL (Telintra), has been granted orphan drug designation by the US Food and Drug Administration (FDA) for the treatment of myelodysplastic syndrome (MDS). Orphan designation grants potential US market exclusivity to a drug for the treatment of a specified condition for a period of seven years following FDA marketing approval.
Will TELK Continue To Move Higher? Find Out Here
Solazyme Inc. (NASDAQ:SZYM) operates as a renewable oil production company. The Company fuels include microbial-derived jet fuels, bio-diesels, and renewable diesels. The Company also offers marine and microaquatic compounds for health and wellness products. Its products are used for biofuel production, replacements for fossil petroleum, and plant oils in various products ranging from green household cleaning supplies to cosmetics and foods. The Company serves renewable energy and industrial chemicals markets, as well as specialty ingredients markets in cosmetic, nutritional, and pharmaceutical products.
Shares of Solazyme, Inc. (NASDAQ: SZYM) are trading at $7.05 and is -11.48% of its 50-day Moving Average price of $7.9644 and -31.64% from its 200-day Moving Average price of $10.3123. The average trading volume is 571433 shares and its market capitalization is $429.2M.
For a FREE INSTANT ANALYSIS of SZYM, please visit here
Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)